{"DataElement":{"publicId":"6570070","version":"1","preferredName":"Bladder Squamous Cell Carcinoma and Adenocarcinoma AJCC Edition 8 Pathologic Tumor T Category","preferredDefinition":"Extent of the primary bladder squamous cell carcinoma and adenosarcoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"BSCAC_AJC8_PTH_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6568895","version":"1","preferredName":"Bladder Neoplasm Squamous Cell Carcinoma And Adenocarcinoma Pathologic T Category","preferredDefinition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra._A benign or malignant tissue growth resulting from uncontrolled cell proliferation._A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"2206698v1.0:6568893v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6568893","version":"1","preferredName":"Squamous Cell Carcinoma And Adenocarcinoma Pathologic T Category","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.:Caused by or altered by or manifesting disease or pathology.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"6568893v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9766FE-A695-04C1-E053-F662850AC1B4","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7B9766FE-A6A6-04C1-E053-F662850AC1B4","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8-30-19 tmt released.; 11-27-18 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6569174","version":"1","preferredName":"Bladder Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this classification system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6569174v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pT2a","valueDescription":"Bladder Cancer pT2a TNM Finding v8","ValueMeaning":{"publicId":"6569190","version":"1","preferredName":"Bladder Cancer pT2a TNM Finding v8","longName":"6569190","preferredDefinition":"Bladder cancer with tumor invading superficial muscularis propria (inner half). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT2a TNM Finding v8","conceptCode":"C140399","definition":"Bladder cancer with tumor invading superficial muscularis propria (inner half). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-1885-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBEAD2D-B862-1694-E053-F662850A2124","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"pT2b","valueDescription":"Bladder Cancer pT2b TNM Finding v8","ValueMeaning":{"publicId":"6569188","version":"1","preferredName":"Bladder Cancer pT2b TNM Finding v8","longName":"6569188","preferredDefinition":"Bladder cancer with tumor invading deep muscularis propria (outer half). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT2b TNM Finding v8","conceptCode":"C140400","definition":"Bladder cancer with tumor invading deep muscularis propria (outer half). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-185F-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBEAD2D-B876-1694-E053-F662850A2124","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"pT3a","valueDescription":"Bladder Cancer pT3a TNM Finding v8","ValueMeaning":{"publicId":"6569184","version":"1","preferredName":"Bladder Cancer pT3a TNM Finding v8","longName":"6569184","preferredDefinition":"Bladder cancer with tumor invading perivesical soft tissue, microscopically. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT3a TNM Finding v8","conceptCode":"C140402","definition":"Bladder cancer with tumor invading perivesical soft tissue, microscopically. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-1813-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBEAD2D-B88A-1694-E053-F662850A2124","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"pT3b","valueDescription":"Bladder Cancer pT3b TNM Finding v8","ValueMeaning":{"publicId":"6569182","version":"1","preferredName":"Bladder Cancer pT3b TNM Finding v8","longName":"6569182","preferredDefinition":"Bladder cancer with tumor invading perivesical soft tissue, macroscopically (extravesical mass). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT3b TNM Finding v8","conceptCode":"C140403","definition":"Bladder cancer with tumor invading perivesical soft tissue, macroscopically (extravesical mass). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-17ED-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBEAD2D-B89E-1694-E053-F662850A2124","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Bladder Cancer pT4b TNM Finding v8","ValueMeaning":{"publicId":"6569176","version":"1","preferredName":"Bladder Cancer pT4b TNM Finding v8","longName":"6569176","preferredDefinition":"Bladder cancer with extravesical tumor invading pelvic wall, abdominal wall. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT4b TNM Finding v8","conceptCode":"C140406","definition":"Bladder cancer with extravesical tumor invading pelvic wall, abdominal wall. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-177B-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-1794-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Bladder Cancer pT4a TNM Finding v8","ValueMeaning":{"publicId":"6569178","version":"1","preferredName":"Bladder Cancer pT4a TNM Finding v8","longName":"6569178","preferredDefinition":"Bladder cancer with extravesical tumor invading directly into prostatic stroma, uterus, vagina. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT4a TNM Finding v8","conceptCode":"C140405","definition":"Bladder cancer with extravesical tumor invading directly into prostatic stroma, uterus, vagina. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-17A1-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-17BA-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"T4","valueDescription":"Bladder Cancer pT4 TNM Finding v8","ValueMeaning":{"publicId":"6569180","version":"1","preferredName":"Bladder Cancer pT4 TNM Finding v8","longName":"6569180","preferredDefinition":"Bladder cancer with extravesical tumor directly invading any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT4 TNM Finding v8","conceptCode":"C140404","definition":"Bladder cancer with extravesical tumor directly invading any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-17C7-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-17E0-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"T3","valueDescription":"Bladder Cancer pT3 TNM Finding v8","ValueMeaning":{"publicId":"6569186","version":"1","preferredName":"Bladder Cancer pT3 TNM Finding v8","longName":"6569186","preferredDefinition":"Bladder cancer with tumor invading perivesical soft tissue. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT3 TNM Finding v8","conceptCode":"C140401","definition":"Bladder cancer with tumor invading perivesical soft tissue. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-1839-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-1852-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"T2","valueDescription":"Bladder Cancer pT2 TNM Finding v8","ValueMeaning":{"publicId":"6569192","version":"1","preferredName":"Bladder Cancer pT2 TNM Finding v8","longName":"6569192","preferredDefinition":"Bladder cancer with tumor invading muscularis propria. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT2 TNM Finding v8","conceptCode":"C140398","definition":"Bladder cancer with tumor invading muscularis propria. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-18AB-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-18C4-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"T1","valueDescription":"Bladder Cancer pT1 TNM Finding v8","ValueMeaning":{"publicId":"6569194","version":"1","preferredName":"Bladder Cancer pT1 TNM Finding v8","longName":"6569194","preferredDefinition":"Bladder cancer with tumor invading lamina propria (subepithelial connective tissue). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT1 TNM Finding v8","conceptCode":"C140397","definition":"Bladder cancer with tumor invading lamina propria (subepithelial connective tissue). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-18D1-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-18EA-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Bladder Cancer pTis TNM Finding v8","ValueMeaning":{"publicId":"6569196","version":"1","preferredName":"Bladder Cancer pTis TNM Finding v8","longName":"6569196","preferredDefinition":"Bladder cancer with a finding of urothelial carcinoma in situ: \"flat tumor\". (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pTis TNM Finding v8","conceptCode":"C140396","definition":"Bladder cancer with a finding of urothelial carcinoma in situ: \"flat tumor\". (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-18F7-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-1910-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"Ta","valueDescription":"Bladder Cancer pTa TNM Finding v8","ValueMeaning":{"publicId":"6569198","version":"1","preferredName":"Bladder Cancer pTa TNM Finding v8","longName":"6569198","preferredDefinition":"Bladder cancer with a finding of non-invasive papillary carcinoma. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pTa TNM Finding v8","conceptCode":"C140395","definition":"Bladder cancer with a finding of non-invasive papillary carcinoma. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-191D-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-1936-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"T0","valueDescription":"Bladder Cancer pT0 TNM Finding v8","ValueMeaning":{"publicId":"6569200","version":"1","preferredName":"Bladder Cancer pT0 TNM Finding v8","longName":"6569200","preferredDefinition":"Bladder cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT0 TNM Finding v8","conceptCode":"C140394","definition":"Bladder cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-1943-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-195C-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"TX","valueDescription":"Bladder Cancer pTX TNM Finding v8","ValueMeaning":{"publicId":"6569202","version":"1","preferredName":"Bladder Cancer pTX TNM Finding v8","longName":"6569202","preferredDefinition":"Bladder cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pTX TNM Finding v8","conceptCode":"C140393","definition":"Bladder cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-1969-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACAC60-1982-5163-E053-F662850AB56B","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6569173","version":"1","preferredName":"Bladder Cancer TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this classification system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140380:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer TNM Finding v8","conceptCode":"C140380","definition":"A finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this classification system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACAC60-174E-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BACAC60-175F-5163-E053-F662850AB56B","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"KNABLEJ","dateModified":"2020-08-01","changeDescription":"8-20-19 released per MC.; 11-27-18 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000515","version":"1","longName":"Bladder","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic T category","type":"Preferred Question Text","description":"Pathologic T category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BBC363E-A5B6-5575-E053-F662850A9F82","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-28","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8-30-19 TMT released per MC.; 11/28/2018 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}